Insights

“Full description” Requirement for Pharmaceutical Patents Considered by APO | Boehringer Ingelheim Animal Health USA Inc. v Zoetis Services LLC [2022] APO 42
Read story
Where are the Instructions? How is the enablement requirement applied to Gene-therapy patents in Australia?
Read story
All is not lost | Grace Period for Australian Patents and Extensions of Time in Canva Pty Ltd [2021] APO 35
Read story
It's About Time | Trade mark opposition deadlines
Read story
OOPS! I found a mistake in a Trade Mark Application. Can it be fixed?
Read story
Don’t Leave it to Chance | Get the Design Formalities Right
Read story
12 month ‘grace period’ introduced for Australian Registered Designs and other reforms
Read story
Australian Trade Mark Opposition Guide | A cost benefit analysis
Read story
World First Australian Court Rules a Machine Can be an Inventor | Thaler v Commissioner of Patents [2021] FCA 879
Read story
Diagnosis Positive - Patentability of Diagnostic Methods in Australia Confirmed in Ariosa Diagnostics, Inc v Sequenom, Inc [2021] FCAFC 101
Read story
Indigenous Knowledge consultations | IP Australia
Read story